Multiplikator Forward P/S capsovision.com (CV)

The implementation of smart video capsules, which have replaced invasive gastrointestinal examinations, is driving the price action for CapsoVision Inc (CV). The forward price-to-sales ratio visualizes this trend, where 22.60 captures the magnitude of this parameter. The business foundation rests on the CapsoCam patent, which ensures patient comfort during examinations, while the high technological complexity of omnidirectional wireless endoscopes securely protects the company's market position.

CapsoVision, Inc. - Multiplikator Forward P/S CV (periode 03.07.2025 - 13.11.2026)

Rincian metrik komprehensif lan analitis capsovision.com (CV)

- rega saiki lan proyeksi nilai saham:

Rega saham CapsoVision|CV - Target median analis

- rincian kapitalisasi pasar:

Kapitalisasi pasar CV|CV - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- statistik nilai buku emiten:

Nilai Buku saben Saham CapsoVision Inc|CV - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku capsovision.com|CV - Aset Agregat Perusahaan

- data tingkat utang lan likuiditas finansial:

- rincian asil keuangan lan kelipatan valuasi:

CV - Asil keuangan resik|Bathi sing dikarepake CapsoVision Inc|CV - Kapitalisasi marang bathi resik|Rega marang bathi mangsa ngarep CapsoVision|CV - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA CV|CV - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan CapsoVision Inc|CV - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan capsovision.com|CV - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep CapsoVision Inc

- data total pendapatan lan volume dodolan:

CV - Dodolan perusahaan|Prakiraan volume dodolan CapsoVision|CV - Multiplikator P/S|Rasio rega marang prakiraan pendapatan CV

Analisis wiwitan perusahaan:CV (CapsoVision Medical)

For CapsoVision Inc (CV), the efficiency of the gentle express delivery of fragile endoscopes to clinics directly impacts revenue growth rates, making the analysis of future sales a key tool for capital preservation. The ratio of market value to expected turnover, reflected in the projected price-to-sales capitalization, allows for an assessment of current multiples and determines the degree to which the asset is overbought relative to its fundamental prospects.

Pesaing utama

Multiplikator Forward P/S ABT (Abbott)|Rasio kapitalisasi marang dodolan sing dikarepake Thermo Fisher Scientific Inc. (TMO)|GE Healthcare Corp - Multiplikator Forward P/S|Mettler Toledo Inc (MTD) - Multiplikator forward rega marang pendapatan|WAT: Multiplikator Forward P/S|bio-techne.com (TECH) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Bruker|Rasio rega marang prakiraan pendapatan AZTA|Multiplikator forward rega marang pendapatan VREX (Varex)|SMLR (Semler) - Rega forward marang dodolan|Multiplikator Forward P/S BFLY (Butterfly Network, Inc.)|mesalabs.com (MLAB) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|QSI - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan Nano-X Imaging (NNOX)|QTRX (Quanterix Corp) - Multiplikator forward rega marang pendapatan|908 Devices Corporation (MASS) - Multiplikator Forward P/S|MXCT (MaxCyte, Inc.) - Multiplikator Forward P/S|Rapid Micro (RPID) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Seer (SEER)|HYPR: Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan FONAR Corp FONR|DXR - Multiplikator forward rega marang pendapatan|Spectral AI - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep VivoSim Labs|Aclarion, Inc. (ACON) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan AKYA|Multiplikator forward rega marang pendapatan THMO|TLIS (Talis Biomedical Corp) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S TTOO